Latest News and Press Releases

UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancer

STUDIO CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members and longtime...

ART0380 in combination with low-dose irinotecan demonstrated a 50% confirmed overall response rate (cORR) in patients with Ataxia-Telangiectasia Mutated (ATM)-negative1 solid tumors at the...

STUDIO CITY, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members and longtime...

Der Gewebeschnitt-Scanner ZEISS Axioscan 7 spatial biology erlaubt skalierbare Workflow-Automatisierung- Umfassendes Lösungsportfolio für die Herausforderungen in der klinischen Forschung – von...

Slide scanner ZEISS Axioscan 7 spatial biology provides scalable workflow automation - Comprehensive solution portfolio – from multiplex immunofluorescence (mIF) staining reagents to spatial image...

BPGbio presents new research on the power of mitochondrial medicine and protein homeostasis technologies to address aggressive cancers at AACR.

Alberta Cancer Foundation (ACF) is joining the Creative Destruction Lab Cancer program to accelerate commercialization of tech to transform cancer care.

CAMBRIDGE, United Kingdom and NEW YORK, April 15, 2025 – Artios Pharma Limited (“Artios”), a clinical-stage biotech company led by pioneers of DNA damage response (“DDR”) drug development, today...

Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Carcinoid Tumor Market" report has been added to ResearchAndMarkets.com's offering. The global demand for advanced carcinoid tumor treatments is...